<DOC>
	<DOCNO>NCT00685334</DOCNO>
	<brief_summary>This study compare effectiveness two atypical antipsychotic medication , olanzapine aripiprazole , treat people anorexia nervosa .</brief_summary>
	<brief_title>Effectiveness Atypical Antipsychotic Medication Outpatients With Anorexia Nervosa</brief_title>
	<detailed_description>Anorexia nervosa ( AN ) disease disorder eat characterize self-starvation , often leading extreme weight loss difficulty maintain normal weight . Symptoms behavior AN may include distorted body image , obsessive exercise , lack menstruation among woman , binge purge eat behavior , intense fear weight gain . Furthermore , people AN high risk mental disorder , depression anxiety , medical complication , organ damage , heart failure , osteoporosis . Current treatment AN include nutrition counseling , psychotherapy , medication . Previous study suggest certain medication usually use treat schizophrenia , also know atypical antipsychotic drug , may helpful treat people AN . Specifically , atypical antipsychotic medication olanzapine aripiprazole may effective improve overall symptom AN restore weight normal level . This study compare effectiveness olanzapine aripiprazole treat people AN . Participation study last 12 week . All participant first undergo baseline assessment include questionnaire interview AN symptom , physical exam , vital sign measurement , electrocardiograph ( EKG ) , blood draw . Participants assign randomly 12 week treatment daily olanzapine aripiprazole . Participants meet study doctor weekly 12 week treatment . During visit , study doctor monitor participant ' progress , medication dosage , vital sign , side effect . In addition , participant undergo repeat blood draw every 4 week repeat questionnaire every month treatment period . Upon complete 12 week treatment , participant repeat baseline assessment .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Meets DSMIV criterion AN ( DSMIV criterion amenorrhea strictly apply , patient show clinically indistinguishable full criterion AN ) Body mass index ( BMI ) less 19 kg/m2 great 14 kg/m2 ( BMI 19 equivalent approximately 85 % ideal body weight [ IBW ] accord Metropolitan Life standard , BMI 14 equivalent approximately 65 % IBW ) Unwilling pursue inpatient treatment BMI le 18 kg/m2 Free psychotropic ( e.g. , antidepressant , antianxiety , mood stabilizer , antipsychotic ) medication 2 week study entry ( free 4 week study entry take fluoxetine antipsychotic medication ) Prior treatment AN Any medical psychiatric problem require urgent clinical attention ( e.g. , metabolic disturbance , acute suicidality ) and/or significant comorbid illness likely benefit propose treatment Significant orthostatic high blood pressure ( systolic change great 30 mmHg upon change supine stand position ) Allergy olanzapine aripiprazole Commencing psychotherapy community within 3 month study entry Diabetes mellitus , fast serum glucose great 120 mg/dL nonfasting serum glucose le 140 mg/dL Known history current past jaundice Known history narrow angle glaucoma Active substance abuse dependence Schizophrenia , schizophreniform disorder , bipolar illness Movement disorder presence tic History tardive dyskinesia History seizures Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Atypical Antipsychotics</keyword>
	<keyword>Anorexia Nervosa</keyword>
</DOC>